Scarica l'app Stockscreener
58.44
0.88%
-0.52
Dopo l'orario di chiusura:
58.43
-0.010
-0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CYTK Giù?
Forum
Previsione
Frazionamento azionario
Cytokinetics Inc Borsa (CYTK) Ultime notizie
Cytokinetics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Levi & Korsinsky Reminds Cytokinetics, Incorporated Investors of the Pending Class Action ... - Bluefield Daily Telegraph
Levi & Korsinsky Reminds Cytokinetics, Incorporated - GlobeNewswire
Key facts: Cytokinetics NDA submission triggers share price drop; lawsuit filed - TradingView
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Globe and Mail
109,120 Options and 73,535 RSUs: Cytokinetics Grants Equity Inducements for New Hires - Stock Titan
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NewMediaWire
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Cytokinetics, Incorporated Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationCYTK - Morningstar
ROSEN, A LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
ROSEN, A LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK - GlobeNewswire Inc.
Cytokinetics (CYTK) CEO Blum sells $300k in shares - Investing.com India
Class Action Filed Against Cytokinetics, Incorporated - GlobeNewswire
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - GlobeNewswire Inc.
Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Faruqi & Faruqi Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025CYTK - FinancialContent
CYTK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cytokinetics, Incorporated Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, - GlobeNewswire
Lost Money on Cytokinetics, Incorporated (CYTK)? Contact Levi & Korsinsky to Join Class Action Before November 17, 2025 - Newsfile
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - PR Newswire
Should I hold or sell Cytokinetics Incorporated stock in 20252025 Market Sentiment & Fast Moving Stock Trade Plans - newser.com
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - GlobeNewswire Inc.
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit - Eastern Progress
Cytokinetics stock hits 52-week high at 61.48 USD By Investing.com - Investing.com Nigeria
Cytokinetics stock hits 52-week high at 61.48 USD - Investing.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cytokinetics, - GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before ... - Caledonian Record
Recover Investment Losses: Class Action Initiated Against Cytokinetics, Incorporated (CYTK) - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming DeadlinesCYTK - PR Newswire
Is Cytokinetics Incorporated forming a bottoming base2025 Market Overview & Capital Efficiency Focused Strategies - newser.com
Is it time to cut losses on Cytokinetics Incorporated2025 Performance Recap & High Conviction Investment Ideas - newser.com
Aberdeen Group plc Buys 320,508 Shares of Cytokinetics, Incorporated $CYTK - MarketBeat
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK)Contact Levi & Korsinsky Before November 17, 2025 - ACCESS Newswire
Boston Herald - FinancialContent
Cytokinetics, Incorporated $CYTK Stake Increased by Mirae Asset Global Investments Co. Ltd. - Defense World
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI to Contact the Firm About their Rights in Filed Class Action Lawsuits - GlobeNewswire
ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages - GlobeNewswire
Shareholders of Cytokinetics, Incorporated (CYTK): Protect Your Rights Before November 17, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investors who lost money on Cytokinetics, Incorporated(CYTK) should contact Levi & Korsinsky about pending Class ActionCYTK - PR Newswire
State of Alaska Department of Revenue Decreases Stake in Cytokinetics, Incorporated $CYTK - Defense World
Weiss Ratings Reiterates "Sell (D-)" Rating for Cytokinetics (NASDAQ:CYTK) - MarketBeat
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionCYTK - Eastern Progress
Cytokinetics, Inc. Hits New 52-Week High at USD 61.42 - Markets Mojo
Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated. Investors - GlobeNewswire
How Cytokinetics Incorporated stock benefits from tech adoptionTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com
Top chart patterns to watch in Cytokinetics IncorporatedWeekly Stock Report & Step-by-Step Swing Trade Plans - newser.com
Duchenne Muscular Dystrophy Drugs Market Global Forecast 2025-2032: Sarepta, Pfizer, BioMarin, Roche, Bayer, Solid Biosciences, Cytokinetics, and NS Pharma Drive Innovation and Commercial Expansion - Yahoo
Cytokinetics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Cytokinetics’ SWOT analysis: aficamten’s potential reshapes HCM treatment landscape - Investing.com
Cytokinetics, Inc. Hits New 52-Week High at $61.00 - Markets Mojo
Cytokinetics Shareholder Alert By Former Louisiana Attorney - GlobeNewswire
Insider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,000 Shares - MarketBeat
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):